documents: FDA-1999-D-0081-0075
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1999-D-0081-0075 | FDA | FDA-1999-D-0081 | Reference 22 Sastry et al 2005 re Testing of Retroviral Vector-Based Human Gene Therapy Products for Replication Competent Retrovirus During Product Manufacture and Patient Follow-up; Guidance for Industry | Supporting & Related Material | Background Material | 2020-01-30T05:00:00Z | 2020 | 1 | 2020-03-09T15:46:18Z | 0 | 0 | 090000648430e511 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref